| 000 | 01836 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515150054.0 | ||
| 264 | 0 | _c20090202 | |
| 008 | 200902s 0 0 eng d | ||
| 022 | _a0179-7158 | ||
| 024 | 7 |
_a10.1007/s00066-008-1833-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMurakami, Naoya | |
| 245 | 0 | 0 |
_aUrethral dose and increment of international prostate symptom score (IPSS) in transperineal permanent interstitial implant (TPI) of prostate cancer. _h[electronic resource] |
| 260 |
_bStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] _cOct 2008 |
||
| 300 |
_a515-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xtherapeutic use |
| 650 | 0 | 4 |
_aBrachytherapy _xmethods |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIodine Radioisotopes _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPerineum |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xblood |
| 650 | 0 | 4 | _aRadiation Dosage |
| 650 | 0 | 4 | _aRadiometry |
| 650 | 0 | 4 |
_aUrethra _xradiation effects |
| 700 | 1 | _aItami, Jun | |
| 700 | 1 | _aOkuma, Kae | |
| 700 | 1 | _aMarino, Hiroshi | |
| 700 | 1 | _aNakagawa, Keiichi | |
| 700 | 1 | _aBan, Tsukasa | |
| 700 | 1 | _aNakazato, Moritoshi | |
| 700 | 1 | _aKanai, Kazuyoshi | |
| 700 | 1 | _aNaoi, Kuniji | |
| 700 | 1 | _aFuse, Masashi | |
| 773 | 0 |
_tStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] _gvol. 184 _gno. 10 _gp. 515-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00066-008-1833-3 _zAvailable from publisher's website |
| 999 |
_c18473012 _d18473012 |
||